IBS-D
Conditions
Interventions
Treatment Group:Invigorating spleen and strengthening intestines
Control Group: Trimebutine
Sponsors
Beijing hospital of TCM Shunyi hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Accord with IBS-D western medicine Rome ? diagnostic standard; (2) Accord with TCM syndrome differentiation of liver stagnation and spleen deficiency syndrome; (3) Aged 18 to 65 years old, males or females; (4) Informed consent, voluntary test, informed consent process in line with the regulations of GCP.
Exclusion criteria
Exclusion criteria: (1) Infectious diarrhea; (2) Diarrhea caused by systemic diseases, poisoning,and malignant tumor; (3) Complicated with cardio-cerebrovascular, hepatorenal, endocrine, hematopoietic system severe primary disease; (4) Pregnant or lactating women; (5) Allergic constitution; (6) Mental disease, suspected or indeed a history of alcohol or substance abuse; (7) Other lesions that reduce the possibility of grouping or complicate grouping, According to the researcher's judgment; (8) Patients who are participating in other clinical trials of drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS-Bss;abdominal pain;stool character; | — |
Countries
China
Contacts
Public ContactWang Jidong
Beijing hospital of TCM Shunyi hospital
Outcome results
None listed